Tiefpreis
CHF227.20
Print on Demand - Exemplar wird für Sie besorgt.
Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.
Easy to use, high-yield format features each type of lymphoma in an individual chapter Each chapter includes discussion of special biologic indicators, prognostic factors, and treatment of firstline disease and relapse Unique chapters cover cutting-edge developments in the employ of monoclonal antibodies, targeted molecules, and stem cell transplant
Klappentext
Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.
Inhalt
Chapter 1
The World Health Organization Classification of Lymphoid Neoplasms
Alejandra Carvajal-Cuenca, Stefano A. Pileri, and Elias Campo
Chapter 2
Genomic Analysis of B-Cell Lymphomas
R. Eric Davis
Chapter 3
Molecular Profiling of Peripheral T-cell Lymphomas
Pier Paolo Piccaluga and Stefano A. Pileri
Chapter 4
Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
Emili Montserrat
Chapter 5
Waldenström's Macrogloblinemia/Lymphoplasmacytic Lymphoma
Steven P. Treon and Giampaolo Merlini
Chapter 6
MALT Lymphoma (Extranodal Marginal Zone B-Cell Lymphoma)
Emanuele Zucca, Francesco Bertoni, and Franco Cavalli
Chapter 7
Splenic Marginal Zone Lymphoma
Catherine Thieblemont, Frederic Davi, and Josette Brière
Chapter 8
Nodal Marginal Zone Lymphoma
Eva K. Kimby
Chapter 9
Follicular Lymphoma
Judith Trotman and Gilles Salles
Chapter 10
Mantle Cell Lymphoma
Christian Schmidt and Martin H. Dreyling
Chapter 11
Diffuse Large B-Cell Lymphoma
Fabrice Jardin and Hervé Tilly
Chapter 12
Primary Mediastinal B-Cell Lymphoma (PMBL)
Kieron M. Dunleavy, Cliona Grant, and Wyndham H. Wilson
Chapter 13
T-Cell Lymphomas
Basem M. William and Julie M. Vose
Chapter 14
Burkitt Lymphoma
Dieter Hoelzer and Thomas Burmeister
Chapter 15
Lymphoblastic Lymphoma
Gautam Borthakur and Susan M. O'Brien
Chapter 16
AIDS Related Lymphoma
Nicolas Mounier and Michele Spina
Chapter 17
Post-Transplant Lymphomas
Jennifer A. Kanakry, Yvette L. Kasamon, and Richard F. Ambinder
Chapter 18
Cutaneous B Cell Lymphoma
Bouthaina S. Dabaja
Chapter 19
Cutaneous T-cell LymphomasMycosis Fungoides and Sézary Syndrome
Madeleine Duvic
Chapter 20
Central Nervous System Lymphoma
Tracy T. Batchelor, Elizabeth R. Gerstner, and Gerald Illerhaus
Chapter 21
Monoclonal Antibodies for Lymphoma
Guillaume Cartron and Philippe Solal Céligny
Chapter 22
Novel Agents Targeting Oncogenic Pathways in Lymphoma
Anas Younes
Chapter 23
Stem Cell Transplantation for Non-Hodgkin's Lymphomas
Chitra Hosing and Richard E. Champlin
Chapter 11
Diffuse Large B-Cell Lymphoma
Fabrice Jardin and Hervé Tilly
Chapter 12
Primary Mediastinal B-Cell Lymphoma (PMBL)
Kieron M. Dunleavy, Cliona Grant, and Wyndham H. Wilson
Chapter 13
T-Cell Lymphomas
Basem M. William and Julie M. Vose
Chapter 14
Burkitt Lymphoma
Dieter Hoelzer and Thomas Burmeister
Chapter 15
Lymphoblastic Lymphoma
Gautam Borthakur and Susan M. O'Brien
Chapter 16
AIDS Related Lymphoma
Nicolas Mounier and Michele Spina
Chapter 17
Post-Transplant Lymphomas
Jennifer A. Kanakry, Yvette L. Kasamon, and Richard F. Ambinder
Chapter 18
Cutaneous B Cell Lymphoma
Bouthaina S. Dabaja
Chapter 19
Cutaneous T-cell LymphomasMycosis Fungoides and Sézary Syndrome
Madeleine Duvic
Chapter 20
Central Nervous System Lymphoma
Tracy T. Batchelor, Elizabeth R. Gerstner, and Gerald Illerhaus
Chapter 21
Monoclonal Antibodies for Lymphoma
Guillaume Cartron and Philippe Solal Céligny
Chapter 22
Novel Agents Targeting Oncogenic Pathways in Lymphoma
Anas Younes
Chapter 23
Stem Cell Transplantation for Non-Hodgkin's Lymphomas
Chitra Hosing and Richard E. Champlin